Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (16056)	9/11/2002 10:06:26 AM
From: aknahow	Read Replies (1) \| Respond to of 17367

Xoma's version of "give us your hungry and your poor", is give us your patents and expression technology. You can have use of our technology for free, but remember you claimed in public and in court you were not using it. You claimed you were using your own patents and own technology, which you have just assigned to us. BTW this technology you are using, that is NOT FREE and as well as licensing it back to you Xoma can license it to others. But the agreement will look like a victory for BSTE. Even Wohanka will be fooled. Or at least one of him will. Who know's what some of the other wohankitos will think or post. BSTE patents which mention Dower patents: Results of Search in 1996-2002 db for: (biosite AND dower): 8 patents. Hits 1 through 8 out of 8 PAT. NO. Title 1 6,420,113 Chimeric polyclonal antibodies 2 6,258,530 Surface expression libraries of randomized peptides 3 6,207,395 Diagnostic assays for detection of Entamoeba histolytica 4 6,057,098 Polyvalent display libraries 5 6,027,933 Surface expression libraries of heteromeric receptors 6 5,871,974 Surface expression libraries of heteromeric receptors 7 5,770,434 Soluble peptides having constrained, secondary conformation in solution and method of making same 8 5,698,426 Surface expression libraries of heteromeric receptors